Hereditary Leiomyomatosis and Renal Cell Cancer
📧 Sign up to get email alerts when something new happens for Hereditary Leiomyomatosis and Renal Cell Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy [NA]
This is an update on a clinical research study (NCT04623502) investigating kidney and urothelial tumor metabolism in patients undergoing sur…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: MyVHL: Patient Natural History Study
This clinical trial update describes the MyVHL: Patient Natural History Study (NCT03749980), an observational study currently recruiting to …
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer [Phase 2]
A phase II trial evaluating the combination of bevacizumab and erlotinib in patients with advanced hereditary leiomyomatosis and renal cell …
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin [Phase 2]
A randomized Phase 2 pilot trial evaluating botulinum toxin for treating cutaneous leiomyomas in hereditary leiomyomatosis and renal cell ca…